Answers are grounded in this paper and cite their sources.
This study aims to synthesize ZnO nanoparticles at different calcination temperatures (300 o C, 400 o C, 500 o C, and 600 o C) using the green synthesis method by aquoes Extract of G. mangostana leaves as a bioreductor of ZnO nanoparticles. The active groups contained in mangosteen leaf extract act as a bioreductor and capping agent, assisting in the synthesis of nanoparticles. The characterization of ZnO NPs using aquoes extract of G. mangostana leaves bioreductor at different calcination temperatures was evaluated by a Particle size analyzer (PSA), scanning electron microscope (SEM), energy dispersive X-ray (EDX), X-ray diffractometer (XRD), and Fourier transform infrared (FTIR). Characterization results using PSA showed an average particle size between 641.97 nm − 915.94 nm. SEM showed some particles in nanoform and agglomeration. EDX showed that the elements of ZnO NPs consisted of Zn and oxygen. XRD showed a specific peak of ZnO crystallinity at 2θ = 36.25 o , with a crystal size of 40.98–46.92 nm, and FTIR showed the presence of ZnO vibrations at cm − 1 and the absorption peak of the -OH functional group at 3330.58–3415.04. In conclusion, ZnO NPs with aquoes Extract of G. mangostana leaves as a bioreductor could synthesize at 300 o C with a smaller size than 600 o C.
No takes yet. Share an insight, caveat, or question.
Rusli et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: